For decades, EMS has relied on blood component therapy, which was favored for its longer shelf life, efficiency, and lower risk of transfusion reactions. However, emerging data suggests that whole blood transfusion in the field could significantly improve survival rates, particularly in rural and remote areas where longer transport times pose additional risks.
The handheld device, the Hemafuse, allows doctors to recycle blood from patients with internal bleeding, reducing the need for donor blood. It collects blood from an internal hemorrhage and is designed to be used in emergency situations.
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.
Alzheimer's diease could potentially be detected with saliva samples, the University of Pittsburgh’s Vascular Medicine Institute receives $20M.